Emgality 120 MG/ML penml
Ended Awarded
- Contract number
- SPE2DR26F6ZBY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,034
Award facts
- Contract value 100% obligated
- $1,034.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Emgality 120 mg/ml pen, a migraine treatment medication. This firm fixed-price delivery order, valued at $1,034.16, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 21, 2025. No set-aside designation was applied to this competitive award.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through the DLA Medical Supply Chain. The company's SPE2DX contract enables it to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This specific delivery order for Emgality exemplifies the company's role in fulfilling specialized pharmaceutical needs for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6ZBY?
SPE2DR26F6ZBY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F6ZBY worth?
The government has obligated $1,034 on SPE2DR26F6ZBY.
Is contract SPE2DR26F6ZBY an order under another contract?
Yes. SPE2DR26F6ZBY is a delivery order under SPE2DR25D3803, an indefinite delivery contract.
Was contract SPE2DR26F6ZBY competed?
The extent of competition for SPE2DR26F6ZBY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award